Clinical trials are very costly and there is no better way for a company of Phylogica's size and based in Perth, to fasttrack its clinical trials in an international arena.
Whether you buy now or not is up to you, but selling at the moment is being too hasty imo.
PYC's collaborations and partnering arrangements are now well-advanced and I expect we will see some positive news from these very soon.
When this happens the share price will rise quite quickly imo as most shareholders will not sell - they realise this is a long term investment with enormous potential.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
0.030(2.16%) |
Mkt cap ! $828.2M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.42 | $1.35 | $262.9K | 189.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7220 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 31411 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |